All Stories

  1. Preoperative assessment of lymph node metastasis in endometrial cancer: A Korean Gynecologic Oncology Group study
  2. An Alternative Triage Strategy Based on Preoperative MRI for Avoiding Trimodality Therapy in Stage IB Cervical Cancer
  3. A human papillomavirus (HPV)-16 or HPV-18 genotype is a reliable predictor of residual disease in a subsequent hysterectomy following a loop electrosurgical excision procedure for cervical intraepithelial neoplasia 3
  4. Clinicopathological aspects of patients with recurrence of borderline ovarian tumors
  5. Major clinical research advances in gynecologic cancer in 2014
  6. Cost-effectiveness of para-aortic lymphadenectomy before chemoradiotherapy in locally advanced cervical cancer
  7. Lymph Node Status Did Not Significantly Improve the Predictability of Survival in Patients With Clinically Early-Stage Endometrial Cancer
  8. Peritoneal cytology: A risk factor of recurrence for non-endometrioid endometrial cancer
  9. Approach to Stage IB1 Cervical Cancer From the Side of Less-Radical Surgery
  10. A Web-Based Nomogram Predicting Para-aortic Nodal Metastasis in Incompletely Staged Patients With Endometrial Cancer
  11. Major clinical research advances in gynecologic cancer in 2013
  12. Cost–utility analysis for platinum-sensitive recurrent ovarian cancer therapy in South Korea: results of the polyethylene glycolated liposomal doxorubicin/carboplatin sequencing model
  13. Hormonal Therapy for Women With Stage IA Endometrial Cancer of All Grades
  14. Major clinical research advances in gynecologic cancer in 2012
  15. Phase II Study of Consolidation Chemotherapy after Adjuvant or Primary Concurrent Chemoradiation Using Paclitaxel and Carboplatin to Treat High-Risk Early-Stage or Locally Advanced Cervical Cancer
  16. Major clinical research advances in gynecologic cancer in 2011
  17. The Journal of Gynecologic Oncology and the Asian Society of Gynecologic Oncology: the history, the present and the future
  18. 20year experience of postoperative radiotherapy in IB-IIA cervical cancer patients with intermediate risk factors: Impact of treatment period and concurrent chemotherapy
  19. How low is low enough? Evaluation of various risk-assessment models for lymph node metastasis in endometrial cancer: a Korean multicenter study
  20. Significance of numbers of metastatic and removed lymph nodes in FIGO stage IB1 to IIA cervical cancer: Primary surgical treatment versus neoadjuvant chemotherapy before surgery
  21. Efficacy of Para-Aortic Lymphadenectomy in Early-Stage Endometrioid Uterine Corpus Cancer
  22. Matched-case comparison for the efficacy of neoadjuvant chemotherapy before surgery in FIGO stage IB1-IIA cervical cancer
  23. Evaluation of serum CA-125 levels for preoperative counseling in endometrioid endometrial cancer: A multi-center study
  24. Role of body mass index as a risk and prognostic factor of endometrioid uterine cancer in Korean women
  25. In reply: A large-scale study on the role of ovarian symptom index is necessary
  26. Vaccination with a Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Cervical Cancer Vaccine in Korean Girls Aged 10-14 Years
  27. Major clinical research advances in gynecologic cancer in 2010
  28. Laparoscopic surgery is a current tide of widely accepted standard procedure for endometrial cancer
  29. Current status of gynecological cancer in China
  30. Differing prognosis of cervical cancer patients with high risk of treatment failure after radical hysterectomy: To the editor
  31. Surgical practice patterns in endometrial cancer: results of the Korean Gynecologic Oncology Group survey
  32. Major clinical research advances in gynecologic cancer 2007
  33. Major clinical research advances in gynecologic cancer 2008
  34. Response to Letter to the Editor
  35. Single nucleotide polymorphism: a new risk factor for endometrial cancer?
  36. Cyclin D1 polymorphism and the risk of endometrial cancer
  37. A randomised study of the postoperative quality of life: laparoscopic UTerine Artery Clipping versus laparoscopy-assisted vaginal hysterectomy for the management of symptomatic uterine fibroids